CI
TAK icon

Clal Insurance’s Takeda Pharmaceutical TAK Stock Holding History

Clal Insurance’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,000
Closed -$625K – 147
2024
Q1 		$625K Hold
45,000
– – 0.01% 109
2023
Q4 		$642K Hold
45,000
– – 0.01% 100
2023
Q3 		$696K Sell
45,000
-2,733,558
-98% -$42.3M 0.01% 100
2023
Q2 		$43.7M Sell
2,778,558
-1,586,942
-36% -$26M 0.52% 51
2023
Q1 		$71.9M Hold
4,365,500
– – 1.08% 28
2022
Q4 		$68.1M Buy
4,365,500
+25,000
+0.6% +$349K 1.02% 33
2022
Q3 		$56.3M Buy
4,340,500
+2,600,000
+149% +$36.2M 0.77% 45
2022
Q2 		$24.4M Buy
+1,740,500
New +$24.8M 0.33% 68

Other funds holding TAK

GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return